Dopaminergic supersensitivity in the striatum
- PMID: 167568
Item in Clipboard
Dopaminergic supersensitivity in the striatum
Adv Neurol.
1975.
No abstract available
Similar articles
-
Behavioral correlates of dopaminergic supersensitivity.Adv Neurol. 1975;9:81-92. Adv Neurol. 1975. PMID: 1170717 No abstract available.
-
The effect of dopamine receptor stimulants on locomotor activity and cyclic AMP levels in the rat striatum.Br J Pharmacol. 1975 Mar;53(3):456P-457P. Br J Pharmacol. 1975. PMID: 165849 Free PMC article. No abstract available.
-
Behavioral effects of direct- and indirect-acting dopaminergic agonists.Adv Biochem Psychopharmacol. 1974;12(0):403-14. Adv Biochem Psychopharmacol. 1974. PMID: 4371765 No abstract available.
-
Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.Res Publ Assoc Res Nerv Ment Dis. 1975;54:233-46. Res Publ Assoc Res Nerv Ment Dis. 1975. PMID: 769114 Review. No abstract available.
-
Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.Adv Neurol. 1990;53:61-6. Adv Neurol. 1990. PMID: 2173376 Review. No abstract available.
Cited by
-
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat.Exp Brain Res. 1986;62(3):567-71. doi: 10.1007/BF00236035. Exp Brain Res. 1986. PMID: 2873048
-
Clinical pharmacokinetics of levodopa in parkinson's disease.Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001. Clin Pharmacokinet. 1976. PMID: 797502 Review.
-
Genetically determined predisposition to convulsions as the result of a generalized defect in the metabolism of catecholamines in the central nervous system.Neurosci Behav Physiol. 1985 Nov-Dec;15(6):456-64. doi: 10.1007/BF01184253. Neurosci Behav Physiol. 1985. PMID: 2869442
-
Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.Psychopharmacology (Berl). 1976 Sep 29;49(3):287-300. doi: 10.1007/BF00426832. Psychopharmacology (Berl). 1976. PMID: 12527
-
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease.Geroscience. 2024 Oct;46(5):4349-4371. doi: 10.1007/s11357-024-01116-0. Epub 2024 Apr 2. Geroscience. 2024. PMID: 38563864 Free PMC article.